It is indicated for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by Terramycin with Polymyxin B Sulfate-susceptible organisms. It may be administered topically alone, or as an adjunct to systemic therapy.It is effective in infections caused by susceptible strains of staphylococci, streptococci, pneumococci.